课题基金 / 基金详情

项目摘要

项目成果

Farren J. Isaacs的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 蛋白质磷酸化是最常见和最关键的翻译后修饰之一 人类体内的信号级联反应。蛋白激酶的磷酸化控制着它们的活性和调节。这个 蛋白激酶包括以下事实进一步强调了通过磷酸化进行调节的重要性 近2%的人类蛋白质组和大量的激酶参与了控制细胞的过程 健康和疾病人类细胞的增殖、运动和凋亡。在识别的同时 近年来,人类蛋白质组中的磷酸化位点有了显著的进展,我们的 对磷酸化级联反应的了解是有限的,这是因为对哪些激酶是明显缺乏了解 负责每一次磷酸化事件和导致 使其目标底物磷酸化的活性激酶。建立与所有人类激酶的直接联系 磷蛋白质组和揭示人类信号网络的系统水平图也保留了下来 定义挑战。由于磷酸化在蛋白质-蛋白质相互作用中起着核心作用,通过磷酸化-蛋白质相互作用。 约束域,能够以全面和公正的方式解决这些问题的新方法 都是需要的。由于不能产生磷蛋白,对蛋白质磷酸化的研究一直受到限制。 具有自然系统的特殊性。基因编码的非标准氨基酸(NSA)最近 使磷酸丝氨酸能够特定地结合到蛋白质中。我们展示了一种基因重新编码的 有机体(Gro),其中所有标签终止密码子都被转换为TAA,并且RF-1的缺失被转换 标记为专用于结合磷酸氨基酸的开放密码子。重要的是,这项技术 突破性进展使人磷蛋白在工程细菌系统中能够定点表达 (即,含有磷丝氨酸的GRO正交翻译系统,OTS)。此外,它还提供了一个平台 技术来解决探索人类亲属组的连接性和功能景观的问题 磷酸结合结构域。在这里,我们的目标是进一步开发和应用这项技术,以生成优化的 解决围绕人类磷酸丝氨酸成分的功能问题的平台 磷酸蛋白质组(目标1)。这些新的、增强的平台将使研究能够识别STE20激酶 底物将直接为未来对多种人类疾病途径的研究提供信息,并定义 阐明人类激酶底物的一般策略(目标2)。最后,我们的目标是确定磷酸化 通常是蛋白质-蛋白质相互作用的驱动因素的位点,随后是对STE20的系统筛选 底物,以协调努力将生物学功能分配给部分人磷蛋白质组 (目标3)。
英文摘要
Project summary Protein phosphorylation is one of the most common and critical post-translational modifications governing signaling cascades in humans. Phosphorylation of protein kinases governs their activity and regulation. The importance of regulation by phosphorylation is further emphasized by the fact that protein kinases comprise nearly 2% of the human proteome and numerous kinases have been implicated in processes that control cell proliferation, motility, and apoptosis in healthy and diseased human cells. While identification of phosphorylation sites within the human proteome has dramatically progressed in recent years, our understanding of phosphorylation cascades is limited due to a distinct lack of knowledge of which kinases are responsible for each phosphorylation event and the specific arrangement of phosphorylation sites leading to an active kinase that phosphorylates its target substrate. Establishing direct connections of all human kinases to the phosphoproteome and revealing a systems-level diagram of human signaling networks also remain defining challenges. Since phosphorylation plays a central role in protein-protein interactions through phospho- binding domains, new approaches that can address these questions in a comprehensive and unbiased fashion are needed. Studying protein phosphorylation has been limited by the inability to generate phosphoproteins with the specificity of natural systems. Genetically encoded non-standard amino acids (NSAAs) have recently enabled site-specific incorporation of phosphoserine into proteins. We showed that a genomically recoded organism (GRO), in which all TAG stop codons were converted to TAA and the deletion of RF-1, converted TAG to an open sense codon dedicated for incorporating phosphoamino acids. Importantly, this technological breakthrough enables site-specific expression of human phosphoproteins in an engineered bacterial system (i.e., GRO containing phosphoserine orthogonal translation system, OTS). Furthermore, it provides a platform technology to address questions probing the connectivity of the human kinome and the functional landscape of phospho-binding domains. Here, we aim to further develop and apply this technology to generate optimized platforms to address functional questions surrounding the phosphoserine component of the human phosphoproteome (Aim 1). These new, enhanced platforms will enable studies to identify STE20 kinase substrates that will directly inform future research into multiple human disease pathways as well as define a general strategy to elucidate human kinase substrates (Aim 2). Finally, we aim to identify phosphorylation sites that are drivers of protein-protein interactions in general, followed by, a systematic screen of the STE20 substrates in a coordinated effort to assign biological function to a portion of the human phosphoproteome (Aim 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing next-generation genomically recoded organisms to synthetically activate biomarkers for drug discovery
  • 批准号:
    10263259
  • 项目类别:
  • 资助金额:
    $58.34万
  • 财政年份:
    2020
  • 负责人:
    Farren J. Isaacs
  • 依托单位:
Developing next-generation genomically recoded organisms to synthetically activate biomarkers for drug discovery
  • 批准号:
    10097168
  • 项目类别:
  • 资助金额:
    $58.8万
  • 财政年份:
    2020
  • 负责人:
    Farren J. Isaacs
  • 依托单位:
Developing next-generation genomically recoded organisms to synthetically activate biomarkers for drug discovery
  • 批准号:
    10618236
  • 项目类别:
  • 资助金额:
    $49.98万
  • 财政年份:
    2020
  • 负责人:
    Farren J. Isaacs
  • 依托单位:
Developing next-generation genomically recoded organisms to synthetically activate biomarkers for drug discovery
  • 批准号:
    10430283
  • 项目类别:
  • 资助金额:
    $57.59万
  • 财政年份:
    2020
  • 负责人:
    Farren J. Isaacs
  • 依托单位:
海外基金